Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04542551 · ClinicalTrials.gov registry record · NA
Pragmatic Approach To Esophageal Dilation
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04542551: Completed NA study, sponsored by University of Louisville.
NCT04542551 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04542551, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the role of a technique called esophageal dilation in patients who complain of trouble swallowing. In patients with esophageal stricture we want to determine if the size of the esophageal dilator makes a difference in symptoms and outcomes. In patients who do not have an obvious esophageal stricture we want to determine if esophageal dilation is an effective therapy in these patients.
Primary Outcome
Evaluate the change in dysphagia (the dysphagia score is used to assess for severity of dysphagia, score ranges from 0 to 5 with the higher score indicates greater degree of severity) in patients without strictures undergoing empiric dilation.
Interventions
- PROCEDURE Sham
- PROCEDURE Dilation 60-Fr non stricture
- PROCEDURE Non severe stricture - dilation with 60-Fr
- PROCEDURE Non severe stricture - dilation with 46-Fr
- PROCEDURE Severe stricture - dilation with 51-Fr
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2023-12-15 |
| Phase | NA |
What the finished NCT04542551 record still lists
NCT04542551 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Sham is the first listed.
NCT04542551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04542551 about?
NCT04542551 is a clinical study titled "Pragmatic Approach To Esophageal Dilation". The purpose of this study is to better understand the role of a technique called esophageal dilation in patients who complain of trouble swallowing. In patients with esophageal stricture we want to determine if the size of the esophageal dilator makes a difference in symptoms and outcomes. In patien...
What is the current status of trial NCT04542551?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2021-03-24. Estimated completion is 2023-12-15.
What interventions are being tested in trial NCT04542551?
The interventions under investigation include: Sham (PROCEDURE), Dilation 60-Fr non stricture (PROCEDURE), Non severe stricture - dilation with 60-Fr (PROCEDURE), Non severe stricture - dilation with 46-Fr (PROCEDURE), Severe stricture - dilation with 51-Fr (PROCEDURE).
Who is sponsoring clinical trial NCT04542551?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04542551's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI